EP 0418347 A4 19941214 - HUMAN MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS
Title (en)
HUMAN MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS
Publication
Application
Priority
- US 31674489 A 19890228
- US 40998689 A 19890919
Abstract (en)
[origin: WO9009805A1] Disclosed herein are eleven human lymphoblastoid cell lines producing monoclonal antibodies directed against human immunodeficiency virus (HIV) proteins gp41 and p24. Also provided are methods for treating HIV-infected individuals using the human monoclonal antibodies and pharmaceutical formulations comprising effective amounts of the human monoclonal antibodies.
IPC 1-7
IPC 8 full level
A61K 39/395 (2006.01); A61P 31/12 (2006.01); C07K 16/00 (2006.01); C07K 16/10 (2006.01); C12N 5/06 (2006.01); C12N 5/07 (2010.01); C12N 5/078 (2010.01); C12N 15/00 (2006.01); C12N 15/09 (2006.01); C12P 21/08 (2006.01); A61K 38/00 (2006.01); C12R 1/91 (2006.01)
CPC (source: EP)
A61P 31/12 (2017.12); C07K 16/1054 (2013.01); C07K 16/1063 (2013.01); A61K 38/00 (2013.01); C07K 2317/732 (2013.01)
Citation (search report)
- [A] WO 8602383 A1 19860424 - PASTEUR INSTITUT [FR], et al
- See references of WO 9009805A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB IT LI LU NL SE
DOCDB simple family (publication)
WO 9009805 A1 19900907; AU 5188590 A 19900926; AU 5225693 A 19940303; AU 651794 B2 19940804; AU 680836 B2 19970814; CA 2028121 A1 19900829; EP 0418347 A1 19910327; EP 0418347 A4 19941214; JP H04505099 A 19920910
DOCDB simple family (application)
US 9001132 W 19900228; AU 5188590 A 19900228; AU 5225693 A 19931208; CA 2028121 A 19900228; EP 90904509 A 19900228; JP 50447290 A 19900228